dc.creatorRojas Vigott, Raquel
dc.creatorLandaverde Recinos, Denis
dc.creatorRivera Delgado, Vanessa
dc.date.accessioned2018-06-11T14:58:54Z
dc.date.accessioned2022-10-20T00:05:15Z
dc.date.available2018-06-11T14:58:54Z
dc.date.available2022-10-20T00:05:15Z
dc.date.created2018-06-11T14:58:54Z
dc.date.issued2017-08-07
dc.identifierhttps://biomedres.us/fulltexts/BJSTR.MS.ID.000257.php
dc.identifier2574-1241
dc.identifierhttps://hdl.handle.net/10669/74878
dc.identifier10.26717/BJSTR.2017.01.000257
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4528712
dc.description.abstractAlveolar soft-part sarcoma is a rare malignant entity with poor prognosis. Chemotherapy has limited activity in this type of sarcoma, we describe here the outcomes of the first case documented in our Institution with metastatic disease, treated exclusively with sunitinib.
dc.languageen_US
dc.rightshttp://creativecommons.org/publicdomain/zero/1.0/
dc.rightsCC0 1.0 Universal
dc.sourceBiomed Journal of Scientific & Technical Research, Vol 1(3)
dc.subjectAlveolar Sarcoma
dc.subjectSunitinib
dc.subjectCosta Rica
dc.subject616.994 728 6 Cánceres
dc.titleAlveolar Soft-Part Sarcoma: A Case Report: Mexico Hospital, San Jose, Costa Rica
dc.typeartículo científico


Este ítem pertenece a la siguiente institución